Premium
Aggravation of food‐related behavior in an adolescent with Prader‐Willi syndrome treated with fluvoxamine and fluoxetine
Author(s) -
Kohn Yoav,
Weizman Abraham,
Apter Alan
Publication year - 2001
Publication title -
international journal of eating disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.785
H-Index - 138
eISSN - 1098-108X
pISSN - 0276-3478
DOI - 10.1002/eat.1062
Subject(s) - fluoxetine , fluvoxamine , appetite , psychology , psychiatry , pharmacotherapy , reuptake inhibitor , obesity , weight gain , medicine , body weight , pediatrics , antidepressant , serotonin , receptor , anxiety
Prader‐Willi Syndrome is a congenital multisystem disorder, characterized by a typical dysmorphism, mental retardation, hyperphagia due to insatiable appetite, and resultant morbid obesity. Psychiatric symptoms include obsessions and temper tantrums. Method Pharmacotherapy is experimental with a few reports of successful fluoxetine treatment. Results We report an aggravation in the food‐related symptoms and a consequent weight gain in an adolescent with Prader‐Willi syndrome, who was treated with fluvoxamine and fluoxetine. © 2001 by John Wiley & Sons, Inc. Int J Eat Disord 30: 113–117, 2001.